![]() |
市場調査レポート
商品コード
1629894
機械式人工呼吸器の世界市場 - 2025年~2033年Global Mechanical Ventilator Market - 2025-2033 |
||||||
カスタマイズ可能
適宜更新あり
|
機械式人工呼吸器の世界市場 - 2025年~2033年 |
出版日: 2024年12月30日
発行: DataM Intelligence
ページ情報: 英文 176 Pages
納期: 即日から翌営業日
|
世界の機械式人工呼吸器市場は、2023年に30億3,000万米ドルに達し、2033年には46億3,000万米ドルに達すると予測され、予測期間2025年~2033年のCAGRは4.2%で成長する見込みです。
機械式人工呼吸器は、自力で呼吸できない患者の自発呼吸を補助または代替する生命維持装置です。制御された気流を肺に送り込み、適切な酸素化と二酸化炭素除去を確実にします。ICU、手術室、救急部などのクリティカルケア環境で使用され、ARDS、COPD、外傷などの疾患による呼吸不全を管理します。侵襲的モデルと非侵襲的モデルがあり、個々の患者のニーズに合わせて換気設定を調整する高度な機能を提供し、転帰を改善し合併症を減少させる。
促進要因と抑制要因
人工呼吸器技術の進歩
世界の機械式人工呼吸器市場は、持ち運び可能な軽量設計、統合モニタリングシステム、ワイヤレス接続、人工知能アルゴリズムなどの技術進歩によって牽引されています。これらの機能により、個別化された換気戦略が可能になり、患者の転帰が改善されます。非侵襲的換気システムは侵襲的処置の必要性を減らし、患者の快適性を高め、リスクを軽減します。こうした技術的改良は、機械式人工呼吸器のコンポーネントを拡大するだけでなく、多様な患者集団における効率的で使い勝手がよく、適応性の高い呼吸ケアソリューションに対する需要の高まりにも対応しています。
例えば、2024年2月、Getinge社はインドでServo-c機械式人工呼吸器を発売しました。この製品は小児および成人患者の多様な呼吸ニーズに対応するように設計されています。この人工呼吸器は肺を保護する治療ツールを提供し、インド全土で病院が高度なヘルスケアソリューションを手頃な価格で利用できるようにするための重要な一歩です。ヘルスケアコストの上昇に伴い、安全で高品質かつ持続可能なソリューションへの投資に注目が集まっています。ゲティンゲのServo-cは、50年以上にわたるServoの実績から、呼吸器サポートを簡素化し、リーズナブルな価格で最先端の機器へのアクセスを提供することを目指しています。
人工呼吸器の高コスト
世界の機械式人工呼吸器市場は、特に中低所得国において、高コストによる課題に直面しています。統合モニタリングシステムや人工知能のような高度な機能を備えた先進的な人工呼吸器は価格が手頃ではなく、小規模な病院や在宅医療の現場での導入が制限されています。メンテナンス、消耗品、オペレーターのトレーニング費用も経済的負担に拍車をかけています。こうした要因が、特にヘルスケア予算が限られている地域での普及を妨げており、市場の成長性に影響を与えています。
例えば、病院の集中治療室で最も使用されている人工呼吸器は高緊急度人工呼吸器です。タービンベースの空気供給と比例ソレノイドガス供給システム(PSOL)を備えたこれらの人工呼吸器は、重度の呼吸器疾患や感染症の患者の治療に使用されます。価格は20,000~5万5,000米ドルで、在宅医療や携帯型人工呼吸器によく使用されます。
The global Mechanical Ventilator market reached US$ 3.03 billion in 2023 and is expected to reach US$ 4.63 billion by 2033, growing at a CAGR of 4.2% during the forecast period 2025-2033.
Mechanical ventilators are life-support devices that assist or replace spontaneous breathing in patients who cannot breathe on their own. They deliver controlled airflow into the lungs, ensuring proper oxygenation and carbon dioxide removal. Used in critical care settings like ICUs, operating rooms, and emergency departments, they manage respiratory failure caused by conditions like ARDS, COPD, or trauma. Available in invasive and non-invasive models, they offer advanced features to tailor ventilation settings to individual patient needs, improving outcomes and reducing complications.
Market Dynamics: Drivers & Restraints
Advancements in Ventilator Technology
The global mechanical ventilator market is driven by technological advancements, including portable and lightweight designs, integrated monitoring systems, wireless connectivity, and artificial intelligence algorithms. These features enable personalized ventilation strategies and improved patient outcomes. Non-invasive ventilation systems reduce the need for invasive procedures, enhancing patient comfort and reducing risks. These technological improvements not only expand the Components of mechanical ventilators but also meet the growing demand for efficient, user-friendly, and adaptable respiratory care solutions across diverse patient populations.
For instance, in February 2024, Getinge has launched its Servo-c mechanical ventilator in India, designed to address the diverse respiratory needs of pediatric and adult patients. The ventilator offers lung-protective therapeutic tools and is a significant step towards making advanced healthcare solutions accessible and affordable for hospitals across India. With rising healthcare costs, there is an increased focus on investing in safe, high-quality, and sustainable solutions. Getinge's Servo-c, drawing from over 50 years of Servo performance, aims to simplify respiratory support and provide access to state-of-the-art equipment at a reasonable price.
High Cost of Ventilators
The global mechanical ventilator market faces challenges due to high costs, particularly in low- and middle-income countries. Advanced ventilators with advanced features like integrated monitoring systems and artificial intelligence are less affordable, limiting adoption in smaller hospitals and homecare settings. Maintenance, consumables, and operator training expenses also add to the financial burden. These factors hinder widespread adoption, especially in regions with limited healthcare budgets, affecting the market's growth potential.
For instance, High-acuity ventilators are the most sought-after type of ventilator for intensive care units in hospitals. These ventilators, which have a turbine-based air supply and proportional solenoid gas delivery system (PSOL), are used to treat patients with severe respiratory illnesses or infections. They can cost between $20,000 and $55,000 and are commonly used in home care and portable ventilators.
The global mechanical ventilator market is segmented based on product type, component, mode of ventilation, end user and region.
Critical Care Ventilators segment is expected to dominate the Mechanical Ventilator market share
The critical care ventilators segment holds a major portion of the mechanical ventilator market share and is expected to continue to hold a significant portion of the mechanical ventilator market share during the forecast period.
Critical care ventilators are essential in managing severe respiratory conditions in intensive care units (ICUs). They provide precise and reliable support for patients with ARDS, COPD, and other critical conditions. Their customizable ventilation modes, real-time monitoring, and integration with hospital systems make them a preferred choice for healthcare professionals. The rising prevalence of life-threatening respiratory disorders and the increasing number of ICU admissions have fueled demand for critical care ventilators, making them a cornerstone of the mechanical ventilator market.
For instance, in July 2024, Air Liquide Medical Systems has introduced the Monnal TEO, a French ventilator designed for intensive care and critical care services. The ventilator, manufactured in France, was developed in collaboration with the Angers University Hospital's intensive care unit, aiming to improve ventilatory care for patients with acute respiratory failure. The company continues to be a pioneer in mechanical ventilation.
Hospitals segment is the fastest-growing segment in Mechanical Ventilator market share
The hospitals segment is the fastest-growing segment in the mechanical ventilator market share and is expected to hold the market share over the forecast period.
Hospitals are the primary users of mechanical ventilators, as they require advanced respiratory care solutions for critically ill patients. The increasing prevalence of respiratory diseases, ICU admissions, and surgeries requiring post-operative ventilation support have boosted the adoption of ventilators in hospitals. Investments in healthcare infrastructure and government initiatives to equip hospitals with advanced medical devices are driving market growth. Hospitals' reliance on ventilators for emergency and long-term care solidifies their central role in shaping the mechanical ventilator market landscape.
For instance, according to Society of Critical Care Medicine Over 5 million patients are admitted to U.S. ICUs annually for monitoring, support, stabilization, management, and comfort. Although diverse, all ICU patients require frequent assessments, clinical expertise, and technological support. They require more clinical expertise than non-ICU patients, requiring a greater focus on comfort and care.
North America is expected to hold a significant position in the Mechanical Ventilator market share
North America holds a substantial position in the mechanical ventilator market and is expected to hold most of the market share due to its advanced healthcare infrastructure, high prevalence of respiratory diseases, FDA clearance and significant healthcare expenditures. The US is particularly significant due to the increasing demand for ventilators due to chronic respiratory conditions like COPD, asthma, and sleep apnea. The aging population and a strong healthcare system contribute to the demand for advanced respiratory care solutions.
For instance, in November 2024, CorVent Medical has received FDA 510(k) clearance for its RESPOND ventilator, a cost-effective, smart ventilation system designed to provide quality care for healthcare systems, providers, and patients. The ventilator is a lightweight, easy-to-use system that combines traditional mechanical ventilation with durable components, eliminating the need for service and maintenance contracts. It comes with a 5-year Limited Warranty, making the total cost of ownership the purchase price. The RESPOND ventilator uses non-proprietary circuits and accessories for long-term affordability.
Moreover, in October 2024, Nihon Kohden America, a global medical technology leader, has introduced the NKV-440 Ventilator System, previously available through OrangeMed, to a wider range of healthcare providers.
Furthermore, government initiatives, such as substantial funding for hospitals and strategic stockpiling of medical equipment, further support the market's growth. North American hospitals invest heavily in ventilator technologies, including high-end critical care ventilators with customizable settings, real-time monitoring, and artificial intelligence-driven decision support.
Europe is growing at the fastest pace in the Mechanical Ventilator market
Europe holds the fastest pace in the mechanical ventilator market and is expected to hold most of the market share due to the aging population, increasing respiratory disorders, and advancements in medical technologies. The region's elderly population, particularly those with chronic respiratory diseases like COPD, pneumonia, and asthma, has a high demand for ventilators in both hospitals and homecare settings. The COVID-19 pandemic accelerated this demand, leading to rapid advancements in ventilator production and government policies to increase availability. Countries like Italy, Germany, and the UK expanded their healthcare budgets to ensure hospitals were well-equipped to handle respiratory crises.
For instance, in November 2024, The British Thoracic Society (BTS) has released its Model of Care for Complex Home Mechanical Ventilation (HMV), aiming to establish standards of care and provide guidance on infrastructure and resourcing for ventilatory failure patients in the UK. HMV is used to support patients with respiratory, neuromuscular, and chest wall disorders, and is beneficial for conditions like Chronic Obstructive Pulmonary Disease, Obesity-Related Respiratory Failure, Motor Neurone Disease, and Duchenne Muscular Dystrophy.
The major global players in the mechanical ventilator market include Medtronic plc, Philips Healthcare, Hamilton Medical AG, GE Healthcare, Dragerwerk AG & Co. KGaA, Vyaire Medical, Inc., Smiths Medical, ResMed Inc, Fisher & Paykel Healthcare Corporation Limited, Allied Healthcare Products, Inc and among others.
Emerging Players
The emerging players in the mechanical ventilator market include AgVa Healthcare, Fritz Stephan GmbH, Dima Italia and among others.
The global mechanical ventilator market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.
LIST NOT EXHAUSTIVE